Evidence map›Paper›PMID 32010253›Full record

ArticleExperimental and therapeutic medicine2020

Pilose antler peptide promotes osteoblast proliferation, differentiation and mineralization via the insulin signaling pathway.

Changjun Yun, Wenjie Qian, Junyi Wu, Chenxi Yuan, Songzhou Jiang, Jinpeng Lv

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Application of polydopamine-modified triphasic PLA/PCL-PLGA/Mg(OH)Frontiers in bioengineering and biotechnology · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Changjun YunDepartment of Orthopedics, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213000, P.R. China.
Wenjie QianDepartment of Orthopedics, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213000, P.R. China.
Junyi WuDepartment of Orthopedics, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213000, P.R. China.
Chenxi YuanDepartment of Orthopedics, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213000, P.R. China.
Songzhou JiangCollege of Pharmaceutical Engineering and Life Sciences, Changzhou University, Changzhou, Jiangsu 213000, P.R. China.
Jinpeng LvDepartment of Orthopedics, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213000, P.R. China.
Jiangsu University · CNChangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a severe bone disease characterized by a decrease in the density and structure of bones, with high risks of fractures. Pilose antler peptide (PAP), extracted and purified from deer antlers, can promote regeneration and fracture healing, and strengthen sinews and bone. To determine whether PAP can promote osteoblast development and to elucidate the molecular mechanisms underlying its functions, the present study investigated the effects of PAP on osteoblast proliferation, differentiation and mineralization, and the role of the insulin signaling pathway using MTT assay, alkaline phosphatase activity assay, western blot analysis and reverse transcription-quantitative PCR. The present results suggested that PAP promoted osteoblast proliferation, differentiation and mineralization

Indexed as

insulin signaling pathwayosteoblastpilose antler peptide

Identifiers

PMID32010253
PMCPMC6966112
OpenAlexW2991926316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.